Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 831

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 831
---
ment Date 
    May 8, 2023 
  
    Fair value of derivative liabilities 
    $954,725 
  
    Less: face amount of debt 
     (555,000)
  
    Derivative expense 
    $399,725 

A reconciliation of the beginning and ending
balances for the derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is
as follows for the year ended December 31, 2024: 

    Contingent Milestone
    Payment  
    Total 
  
    Derivative liabilities –  December 31, 2023 
    $2,306,796  
    $2,306,796 
  
    Change in fair value 
     (1,665,966) 
     (1,665,966)
  
    Derivative liabilities – December 31, 2024 
    $640,830  
    $640,830 

A reconciliation of the beginning and ending
balances for the derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is
as follows for the year ended December 31, 2023: 

    Bridge Shares  
    Warrants  
    Convertible Notes Payable  
    Contingent Milestone Payment  
    Total 
  
    Derivative liabilities – December 31, 2022 
    $834,352  
    $578,164  
    $81,684  
    $-  
    $1,494,200 
  
    Change in fair value 
     13,798  
     (15,320) 
     (1,312) 
     -  
     (2,834)
  
    Fair value at commitment date 
     680,276  
     274,449  
     -  
     -  
     954,725 
  
    Change in fair value prior to conversion or reclassification 
     (105,790) 
     1,455  
     (45,207) 
     -  
     (149,542)
  
    Conversion of convertible promissory notes 
     (1,422,636) 
     -  
     (35,165) 
     -  
     (1,457,801)
  
    Reclass